Previous Close | 0.0063 |
Open | 0.0063 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0056 - 0.0063 |
52 Week Range | 0.0055 - 0.0330 |
Volume | |
Avg. Volume | 953,226 |
Market Cap | 7.247M |
Beta (5Y Monthly) | 21.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0010 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vystar/Rotmans would have singular focus on furniture/bedding industry to be attractive reverse merger opportunityRxAir NewCo would include RxAir®, Vytex® and Fluid Energy ConversionRxAir NewCo dividend record date set for June 30, 2022After 100% RxAir NewCo spin-off, NewCo will issue 9.5% equity to Vystar Worcester, MA, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) announces that it plans to split into two companies via a dividend. In addition to the previously announced s
FEC patented technology has potential for applications in multiple industriesFEC to prioritize air and water purification R&D Worcester, MA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation’s (OTCQB: VYST) Board of Directors has approved plans to add its Fluid Energy Conversion, Inc.(FEC), subsidiary into the previously announced planned spin-off of its RxAir® UV light air purification subsidiary into a publicly traded entity (RxAir NewCo). This is expected to occur in early 2022. The addi
Separation of RxAir® business offers pure-play investment opportunityVystar shareholders on the Record Date of January 5, 2022 to qualify for dividend of RxAir NewCo shares Worcester, MA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation’s (OTCQB: VYST) Board of Directors has approved preliminary plans to spin off the RxAir® UV light air purification business as a separate publicly traded company (RxAir NewCo). Vystar is planning the spin-off to result in Vystar shareholders owning stock in